Purpose

Feasibility and reliability of ultrasound in the inpatient hematology setting.

Conditions

Eligibility

Eligible Ages
Under 25 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  1. Age: 0-25 years old 2. Diagnosis: Patients with a documented diagnosis of sickle cell disease (any genotype) 3. Disposition: Hospitalized for a SCD-related complication (e.g. VOC)

Exclusion Criteria

  1. Patient is considered hemodynamically unstable to undergo consent and study procedures 2. Already has diagnosis of ACS prior to admission to inpatient unit 3. POCUS operator not available

Study Design

Phase
N/A
Study Type
Interventional
Allocation
N/A
Intervention Model
Single Group Assignment
Primary Purpose
Diagnostic
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Ultrasound
Ultrasound days 1, 3, and 5 of hospitalization
  • Device: Point of Care Ultrasound
    Point of Care Ultrasound during hospitalization

Recruiting Locations

Indiana University
Indianapolis, Indiana 46202
Contact:
Seethal Jacob, MD
317-278-9662
seejacob@iu.edu

More Details

Status
Recruiting
Sponsor
Indiana University

Study Contact

Thomas Fisher-Heath, DO
317-944-8784
tcfisher@iu.edu

Detailed Description

Acute chest syndrome (ACS) is a complication of sickle cell disease where individuals have symptoms of fever, low oxygen levels or difficulty breathing in the setting of a new lung finding on chest x-ray. Chest x-ray is a useful tool to identify it but has some side effects. The investigators think ultrasound will be an equally feasible, reliable tool and minimize some of the side effects associated with chest x-ray. Ultrasound is a non-invasive was to obtain an image that does not require radiation.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.